Newsletter
Newsletter Support JNS

Sheba Medical Center

“This is the least we can do to help the Ukrainian people in the face of a brutal Russian invasion,” says Health Minister Nitzan Horowitz.
“It is our moral duty to increase humanitarian aid and extend assistance to the people of Ukraine,” says Health Minister Nitzan Horowitz.
“The goal of this study is to provide the best data-based comparison of hospital reputation and performance across countries,” explained Nancy Cooper, Newsweek’s global editor-in-chief.
The partners will focus on innovation in data driven cardiology, remote pregnancy monitoring and molecular imaging.
CTO of Sheba Beyond, a virtual hospital at Sheba Medical Center, goes with United Hatzalah’s medical mission to set up remote care and monitoring.
The delegation consists of 15 medical personnel and a representative of the Sheba Beyond virtual hospital.
“The world needs new diagnostic tools to help assess aggressive viruses in a non-invasive manner with speed and efficiency,” said Raanan Gefen, chief technology officer of AdOM Advanced Optical Technologies.
The vaccination certificate program has been a point of conflict since the start of the fifth wave and especially in recent weeks, as the country has sent around 10% of students into isolation.
Adults over the age of 60 receive a fourth dose of the COVID-19 vaccine at Meuhedet vaccination center in Jerusalem on Jan. 4, 2022. Photo by Yonatan Sindel/Flash90.
Israeli study: Fourth COVID shot ‘only partially effective’ against Omicron
The goal of the trial was to examine effects on antibody levels and disease prevention, as well as to evaluate safety, said Professor Gili Regev-Yochay of the Sheba Medical Center.
As the number of daily cases continues to rise, Israeli experts admit that COVID policy based almost entirely on shots is proving ineffective.
A young Israeli receives a booster shot of the Pfizer/BioNTech COVID-19 vaccine, Sept. 20, 2021. Photo by Olivier Fitoussi/Flash90.
As Israel approves fourth COVID jab, Moderna booster also being tested
The decision was made with the aim of preventing severe COVID-19 cases in light of the Omicron variant even before data has come in from a study involving 150 employees at Sheba Medical Center.
A study by an Israeli research group, in collaboration with peers from Germany, France, England and the United States, suggests that the course of the fatal neurodegenerative disease can be delayed and even reversed in its early stages.